Flash News
The trial for Berisha is postponed again, due to the lack of prosecutors
Why is a national tender not announced for Sazan? Rama: We choose the offers, the proposal will be examined
Former minister and Socialist MP, Nasip Naço, appears in SPAK
Morning mail/ With 2 lines: What was important yesterday in Albania
Serious in Krujë/ the 42-year-old woman put the newborn baby in a bag and threw it into the river at home
Researchers in Australia are beginning clinical trials of a new type of vaccine against COVID-19 - a nasal spray. Scientists in Brisbane believe the treatment could be more effective against the virus than the AstraZeneca and Pfizer vaccines and would enable the vaccination of patients who are afraid of needles.
Despite coordinated public health campaigns, the vaccination program in Australia has been slow compared to other countries. Australia has faced supply problems, complaints of poor planning by the government while the relatively low level of coronavirus cases has resulted in complacency and reluctance in the community.
Australia is accelerating its immunization campaign. In the future, vaccines may be more easily administered - like a nasal spray created to "attack the virus" as the drug enters the body.
Dr. Paul Griffin, medical director at the Nucleus Network, a research organization that is beginning trials of nasal spray therapy, said that while other drugs primarily protect against the onset of severe symptoms of COVID-19, the vaccine aims to reduce the risk of infection. .
An independent ethics committee in Australia has approved the clinical trials. Researchers say the nasal sprayer may be available within a year or two. VOA